조혈모세포이식 환자에서 발생한 Cytomegalovirus 질환의 특징 : 일개 대학병원에서 최근 10년간의 경험
Characteristics of Cytomegalovirus Diseases among Hematopoietic Stem Cell Transplant Recipients : A 10-year Experience at an University Hospital in Korea
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background : Studies on cytomegalovirus (CMV) diseases in Korean hematopoietic stem cell transplant (HSCT) recipients are lacking and do not reflect the recent trends of advances and changes. Therefore, we tried to analyze the clinical features of CMV diseases in HSCT recipients over the past 10 years at a tertiary university hospital in Korea. Methods : Retrospective review of medical records was done for all adult HSCT patients who received transplant at the Catholic HSCT Center from January 1998 to January 2008. Results : Forty-four cases (2.2%) of CMV diseases were identified. CMV pneumonia was diagnosed in 17 patients, retinitis in 16 patients, enterocolitis in 7 patients, esophagitis 1 patient, gastritis in 1 patient, duodenitis in 1 patient, and hepatitis in 1 patient. The median onset of symptom was 90 days after transplantation. Late CMV diseases accounted for 47.7%. CMV related death varied from 0 to 58.8% according to the involved organ. CMV retinitis was diagnosed relatively later in the course of transplantation mostly in patients who had chronic graft versus host disease (GVHD). On the contrary, CMV enterocolitis mainly occurred in patients who suffered from acute GVHD. The overall concurrent CMV reactivation was documented to be 63.6%; the concurrent CMV reactivation was observed only in 37.5% of patients with retinitis. Conclusions : We observed some differences in the pattern of CMV disease manifestation according to the involved organ and reconfirmed the fact that CMV pneumonia is the most common and fatal disease in HSCT recipients. Additionally, CMV retinitis was not uncommon in HSCT recipients. Since specific marker does not exist in predicting retinitis, regular ocular examination should be done thoroughly, especially in patients with chronic GVHD.
Abstract
Background : Studies on cytomegalovirus (CMV) diseases in Korean hematopoietic stem cell transplant (HSCT) recipients are lacking and do not reflect the recent trends of advances and changes. Therefore, we tried to analyze the clinical features of CMV diseases in HSCT recipients over the past 10 years at a tertiary university hospital in Korea. Methods : Retrospective review of medical records was done for all adult HSCT patients who received transplant at the Catholic HSCT Center from January 1998 to January 2008. Results : Forty-four cases (2.2%) of CMV diseases were identified. CMV pneumonia was diagnosed in 17 patients, retinitis in 16 patients, enterocolitis in 7 patients, esophagitis 1 patient, gastritis in 1 patient, duodenitis in 1 patient, and hepatitis in 1 patient. The median onset of symptom was 90 days after transplantation. Late CMV diseases accounted for 47.7%. CMV related death varied from 0 to 58.8% according to the involved organ. CMV retinitis was diagnosed relatively later in the course of transplantation mostly in patients who had chronic graft versus host disease (GVHD). On the contrary, CMV enterocolitis mainly occurred in patients who suffered from acute GVHD. The overall concurrent CMV reactivation was documented to be 63.6%; the concurrent CMV reactivation was observed only in 37.5% of patients with retinitis. Conclusions : We observed some differences in the pattern of CMV disease manifestation according to the involved organ and reconfirmed the fact that CMV pneumonia is the most common and fatal disease in HSCT recipients. Additionally, CMV retinitis was not uncommon in HSCT recipients. Since specific marker does not exist in predicting retinitis, regular ocular examination should be done thoroughly, especially in patients with chronic GVHD.
참고문헌 (39)
- Mocarski ES, "Cytomegaloviruses in Fields virology" (2007), Lippincott Williams and Wilkins
- Boeckh M, "Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies", Biol Blood Marrow Transplant, 9, pp.543~558 (2003)
- Boeckh M, "Quantitation of cytomegalovirus: methodologic aspects and clinical applications", Clin Microbiol Rev, 11, pp.533~554 (1998)
- Halaburda K, "Limited predictive value of real-time quantitative PCR cytomegalovirus monitoring in the blood. Fatal CMV pneumonia in an autologous stem cell transplant recipient previously treated with alemtuzumab", Ann Transplant, 12, pp.37~40 (2007)
- Ruell J, "Active CMV disease does not always correlate with viral load detection", Bone Marrow Transplant, 40, pp.55~61 (2007)
- Yoo JH, "Five cases of cytomegalovirus infection detected by in situ hybridization and antigenemia assay", J Korean Med Sci, 9, pp.507~512 (1994)
- Kim SC, "Cytomegalovirus infection in stem cell transplantation", Korean J Hematol, 32, pp.388~397 (1997)
- Yoo JH, "Clinical analysis of cytomegalovirus antigenemia after allogeneic bone marrow transplantation and a suggestion of a guideline to initiation of therapy", Korean J Hemato Stem Cell Trans, 2, pp.43~50 (1997)
- Kim JW, "Analysis of twenty-three cases of cytomegalovirus disease", Korean J Infect Dis, 30, pp.251~258 (1998)
- Park SH, "Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation; analysis of risk factors", Korean J Hemato Stem Cell Trans, 5, pp.23~31 (2000)
- 김종광, "동종 말초혈액 조혈모세포이식 후의 거대세포바이러스 감염에 대한 Ganciclovir의 정주 후 경구용 선제치료 효과", 대한혈액학회지, 37(1), pp.5~37 (2002), 대한혈액학회
- Yoo JH, "Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea", Bone Marrow Transplant, 34, pp.497~504 (2004)
- Oh Suk Joong, "The Risk of Cytomegalovirus Infection in Non-myeloablative Peripheral Stem Cell Transplantation Compared with Conventional Bone Marrow Transplantation", Journal of Korean Medical Science, 19(2), pp.172~176 (2004), 대한의학회
- Choi SM, "Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea", Int J Hematol, 81, pp.69~74 (2005)
- Choi SM, "Real-time PCR guided risk-adapted preemptive therapy for prevention of cytomegalovirus diseases in allogeneic hematopoietic stem cell transplantation", Infect Chemother 39 Suppl, 2, pp.S267~ (2007)
- Ljungman P, "Definitions of cytomegalovirus infection and disease in transplant recipients", Clin Infect Dis, 34, pp.1094~1097 (2002)
- Lee GC, "Use of time- saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir", J Clin Microbiol, 43, pp.5003~5008 (2005)
- Rubin RH, "Infection in the organ transplant recipient", pp.2002, Kluwer
- Rubin RH, "The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'", Curr Opin Infect Dis, 20, pp.399~407 (2007)
- Nguyen Q, "Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients", Clin Infect Dis, 28, pp.618~623 (1999)
- de Maar EF, "Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients", Transpl Infect Dis, 5, pp.112~120 (2003)
- Crippa F, "Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation", Clin Infect Dis, 32, pp.214~219 (2001)
- Xhaard A, "Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation", Transplantation, 83, pp.80~83 (2007)
- Eid AJ, "Clinical features and outcomes of cytomegalovirus retinitis after transplantation", Transpl Infect Dis, 10, pp.13~18 (2008)
- Moon JH, "Cytomegalovirus Pneumonia: High-Resolution CT findings in ten non-AIDS immunocompromised patients", Korean J Radiol, 1, pp.73~78 (2000)
- Franquet T, "Muller NL Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS", AJR Am J Roentgenol, 181, pp.1059~1063 (2003)
- Gasparetto EL, "Frare e Silva RL. Cytomegalovirus pneumonia after bone marrow transplantation: high resolution CT findings", Br J Radiol, 77, pp.724~727 (2004)
- Horger MS, "Cytomegalovirus pneumonia after stem cell transplantation: correlation of CT findings with clinical outcome in 30 patients", AJR Am J Roentgenol, 187, pp.636~643 (2006)
- Vogel MN, "Differences and similarities of cytomegalovirus and pneumocystis pneumonia in HIV-negative immunocompromised patients thin section CT morphology in the early phase of the disease", Br J Radiol, 80, pp.516~523 (2007)
- Ju JH, "Pneumocystis carinii Pneumonia Following Stem Cell Transplantation", Korean J Infect Dis, 33, pp.273~279 (2001)
- de Pagter PJ, "Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome", Biol Blood Marrow Transplant, 14, pp.831~839 (2008)
- Hentrich M, "Impact of human herpesvirus-6 after haematopoietic stem cell transplantation", Br J Haematol, 128, pp.66~72 (2005)
- Schulenburg A, "Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation", Ann Hematol, 83, pp.101~106 (2004)
- Fujishima N, "Cytomegalovirus- associated granulomatous gastritis after cord blood transplantation for acute myeloid leukemia", Int J Hematol, 85, pp.362~363 (2007)
- Cruz-Correa M, "Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease", Endoscopy, 34, pp.808~813 (2002)
- He JD, "Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation", Chin Med J (Engl), 121, pp.1285~1289 (2008)
- Miller GG, "Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient", Clin Infect Dis, 42, pp.269~ (2006)
- Chae YS, "Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV- seropositive recipients and donors", Am J Hematol, 83, pp.649~653 (2008)
- Gratwohl A, "Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); European Group for Blood and Marrow Transplantation EBMT (JACIE)", The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products, 통권 : 41, pp.687~705 (2008), Bone Marrow Transplant